Becker Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.22M | Buy |
14,799
+1
| +0% | +$222 | 0.09% | 114 |
|
|
2025
Q4 | $3.38M | Buy |
14,798
+442
| +3% | +$101K | 0.1% | 115 |
|
|
2025
Q3 | $3.32M | Sell |
14,356
-209
| -1% | -$42.6K | 0.1% | 117 |
|
|
2025
Q2 | $2.7M | Sell |
14,565
-61
| -0.4% | -$11.3K | 0.08% | 120 |
|
|
2025
Q1 | $3.06M | Sell |
14,626
-626
| -4% | -$122K | 0.1% | 122 |
|
|
2024
Q4 | $2.71M | Sell |
15,252
-283
| -2% | -$52K | 0.09% | 125 |
|
|
2024
Q3 | $3.07M | Buy |
15,535
+696
| +5% | +$130K | 0.1% | 123 |
|
|
2024
Q2 | $2.55M | Sell |
14,839
-102
| -0.7% | -$16.9K | 0.09% | 121 |
|
|
2024
Q1 | $2.72M | Buy |
14,941
+273
| +2% | +$47K | 0.09% | 119 |
|
|
2023
Q4 | $2.27M | Sell |
14,668
-6,295
| -30% | -$918K | 0.08% | 123 |
|
|
2023
Q3 | $3.12M | Sell |
20,963
-201
| -0.9% | -$29.5K | 0.12% | 111 |
|
|
2023
Q2 | $2.85M | Buy |
21,164
+504
| +2% | +$73.9K | 0.11% | 114 |
|
|
2023
Q1 | $3.29M | Buy |
20,660
+1,558
| +8% | +$238K | 0.13% | 110 |
|
|
2022
Q4 | $3.09M | Sell |
19,102
-206
| -1% | -$31.6K | 0.14% | 93 |
|
|
2022
Q3 | $2.59M | Buy |
19,308
+278
| +1% | +$39.9K | 0.14% | 98 |
|
|
2022
Q2 | $2.92M | Buy |
19,030
+1,144
| +6% | +$175K | 0.14% | 100 |
|
|
2022
Q1 | $2.9M | Sell |
17,886
-42
| -0.2% | -$6.1K | 0.12% | 107 |
|
|
2021
Q4 | $2.43M | Buy |
17,928
+528
| +3% | +$62.4K | 0.1% | 112 |
|
|
2021
Q3 | $1.88M | Sell |
17,400
-104
| -0.6% | -$11.9K | 0.08% | 112 |
|
|
2021
Q2 | $1.97M | Buy |
17,504
+186
| +1% | +$20.9K | 0.08% | 108 |
|
|
2021
Q1 | $1.87M | Buy |
17,318
+74
| +0.4% | +$7.92K | 0.08% | 110 |
|
|
2020
Q4 | $1.85M | Buy |
17,244
+313
| +2% | +$30.1K | 0.09% | 103 |
|
|
2020
Q3 | $1.48M | Sell |
16,931
-1,157
| -6% | -$109K | 0.08% | 104 |
|
|
2020
Q2 | $1.78M | Buy |
18,088
+5,334
| +42% | +$470K | 0.1% | 94 |
|
|
2020
Q1 | $972K | Buy |
12,754
+83
| +0.7% | +$7.07K | 0.06% | 107 |
|
|
2019
Q4 | $1.12M | Buy |
12,671
+971
| +8% | +$80.6K | 0.04% | 104 |
|
|
2019
Q3 | $886K | Sell |
11,700
-1,885
| -14% | -$129K | 0.03% | 102 |
|
|
2019
Q2 | $988K | Buy |
13,585
+284
| +2% | +$22.3K | 0.04% | 104 |
|
|
2019
Q1 | $1.07M | Sell |
13,301
-65
| -0.5% | -$5.32K | 0.04% | 103 |
|
|
2018
Q4 | $1.23M | Sell |
13,366
-1,370
| -9% | -$120K | 0.05% | 93 |
|
|
2018
Q3 | $1.39M | Buy |
14,736
+287
| +2% | +$27.2K | 0.04% | 94 |
|
|
2018
Q2 | $1.34M | Sell |
14,449
-328
| -2% | -$32K | 0.04% | 91 |
|
|
2018
Q1 | $1.4M | Buy |
14,777
+6,075
| +70% | +$667K | 0.05% | 90 |
|
|
2017
Q4 | $842K | Buy |
8,702
+1,518
| +21% | +$143K | 0.03% | 99 |
|
|
2017
Q3 | $638K | Buy |
7,184
+1,929
| +37% | +$147K | 0.02% | 104 |
|
|
2017
Q2 | $381K | Hold |
5,255
| – | – | 0.01% | 112 |
|
|
2017
Q1 | $342K | Hold |
5,255
| – | – | 0.01% | 115 |
|
|
2016
Q4 | $329K | Sell |
5,255
-149
| -3% | -$9.1K | 0.01% | 120 |
|
|
2016
Q3 | $341K | Sell |
5,404
-36
| -0.7% | -$2.33K | 0.01% | 113 |
|
|
2016
Q2 | $337K | Sell |
5,440
-215
| -4% | -$13.1K | 0.01% | 113 |
|
|
2016
Q1 | $323K | Sell |
5,655
-1,100
| -16% | -$61.3K | 0.01% | 103 |
|
|
2015
Q4 | $400K | Buy |
6,755
+935
| +16% | +$53.9K | 0.02% | 107 |
|
|
2015
Q3 | $317K | Hold |
5,820
| – | – | 0.01% | 105 |
|
|
2015
Q2 | $391K | Sell |
5,820
-1,035
| -15% | -$67.6K | 0.02% | 110 |
|
|
2015
Q1 | $401K | Sell |
6,855
-77
| -1% | -$4.65K | 0.02% | 110 |
|
|
2014
Q4 | $454K | Buy |
6,932
+112
| +2% | +$7.06K | 0.02% | 110 |
|
|
2014
Q3 | $394K | Hold |
6,820
| – | – | 0.02% | 111 |
|
|
2014
Q2 | $385K | Hold |
6,820
| – | – | 0.02% | 111 |
|
|
2014
Q1 | $351K | Buy |
6,820
+2,700
| +66% | +$136K | 0.01% | 114 |
|
|
2013
Q4 | $218K | Sell |
4,120
-1,155
| -22% | -$56.8K | 0.01% | 134 |
|
|
2013
Q3 | $236K | Sell |
5,275
-100
| -2% | -$4.43K | 0.01% | 119 |
|
|
2013
Q2 | $222K | Buy |
+5,375
| New | +$235K | 0.01% | 116 |
|
Other funds holding ABBV
VCM
VPM
Becker Capital Management's ABBV Position: Q1 2026 in Review
Becker Capital Management increased its AbbVie (ABBV) stake by 0.01% in Q1 2026, buying an estimated $222 and bringing the position to 14,799 shares worth $3.22M. The position accounts for 0.09% of the portfolio, ranked #114.
Becker Capital Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.38M in Q4 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Becker Capital Management held 14,799 shares of AbbVie worth $3.22M as of Q1 2026.
- Becker Capital Management bought 1 AbbVie share in Q1 2026, an estimated $222.
- AbbVie made up 0.09% of Becker Capital Management's portfolio in Q1 2026, its #114 holding.
- Becker Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Becker Capital Management's AbbVie position peaked at $3.38M in Q4 2025.
- 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Becker Capital Management's 13F filing for Q1 2026, filed 11 May 2026.